Valente J F, Alexander J W
Department of Surgery, University of Cincinnati, College of Medicine, Ohio, USA.
Surg Clin North Am. 1998 Feb;78(1):1-26. doi: 10.1016/s0039-6109(05)70631-9.
The clinical application of our knowledge of the immune barriers to transplantation has advanced allo-organ replacement therapy to the level of routine practice, while simultaneously engendering a critical shortage in available donors. Recent work in xenotransplantation addresses this need. The current understanding of the immune barriers to transplantation has evolved to consider alternate responses to alloantigen, namely acceptance. The delineation and application of recent discoveries in T cell costimulatory events, antigen presentation, and differential T lymphocyte responses are opening pathways towards the development of tolerogenic protocols for use in clinical transplantation. This article presents a review of transplant immunobiology with special attention to antigen presentation and T-cell activation as phases of the immune response relevant to the discussion of transplant tolerance.
我们对移植免疫屏障知识的临床应用已将同种异体器官替代疗法提升至常规医疗水平,与此同时,可用供体却严重短缺。异种移植方面的最新研究满足了这一需求。目前对移植免疫屏障的理解已发展到考虑对同种异体抗原的不同反应,即接受。T细胞共刺激事件、抗原呈递和T淋巴细胞差异反应方面最新发现的描述与应用,正为临床移植中耐受性方案的开发开辟道路。本文对移植免疫生物学进行综述,特别关注抗原呈递和T细胞活化,将其作为与移植耐受讨论相关的免疫反应阶段。